As of Jul 31
| +1.16 / +0.79%|
The 29 analysts offering 12-month price forecasts for Bayer have a median target of 160.59, with a high estimate of 180.25 and a low estimate of 124.54. The median estimate represents a +8.68% increase from the last price of 147.76.
The current consensus among 31 polled investment analysts is to Buy stock in Bayer. This rating has held steady since July, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.